>>Signaling Pathways>> Apoptosis>> Other Apoptosis>>Taccalonolide A

Taccalonolide A

Catalog No.GC37715

Taccalonolide A는 Tacca chantrieri에서 분리된 스테로이드로 세포독성 및 항말라리아 활성을 갖는 미세소관 안정제입니다. Taccalonolide A는 G2-M 축적, Bcl-2 인산화 및 세포 사멸의 시작을 유발합니다. Taccalonolide A는 SK-OV-3 세포에 대해 622nM의 IC50으로 P-당단백질(Pgp) 및 다제내성 단백질 7(MRP7)을 과발현하는 세포주에 대해 시험관 내에서 효과적입니다.

Products are for research use only. Not for human use. We do not sell to patients.

Taccalonolide A Chemical Structure

Cas No.: 108885-68-3

Size 가격 재고 수량
1mg Please Inquire Please Inquire
5mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Taccalonolide A is a microtubule stabilizer, which is a steroid isolated from Tacca chantrieri, with cytotoxic and antimalarial activities[1][2]. Taccalonolide A causes G2-M accumulation, Bcl-2 phosphorylation and initiation of apoptosis[1]. Taccalonolide A is effective in vitro against cell lines that overexpress P-glycoprotein (Pgp) and multidrug resistance protein 7 (MRP7), with an IC50 of 622 nM for SK-OV-3 cells[3]. microtubule[1]

[1]. Tinley TL, et al. Taccalonolides E and A: Plant -derived steroids with microtubule-stabilizing activity. Cancer Res. 2003 Jun 15;63(12):3211-20. [2]. Risinger AL, et al. Taccalonolides: Novel microtubule stabilizers with clinical potential. Cancer Lett. 2010 May 1;291(1):14-9. [3]. Risinger AL, et al. The taccalonolides: microtubule stabilizers that circumvent clinically relevant taxane resistance mechanisms. Cancer Res. 2008 Nov 1;68(21):8881-8.

리뷰

Review for Taccalonolide A

Average Rating: 5 ★★★★★ (Based on Reviews and 32 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Taccalonolide A

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.